A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque Psoriasis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The primary objective of this study is to evaluate the efficacy of HS-20118 compared with placebo in participants with moderate to severe plaque psoriasis.
Epistemonikos ID: 41f08f6706dd83e17203ae6229e13fea33db2fa5
First added on: Aug 14, 2026